Thomas Equals
Chief Executive Officer
Replay available
AIM ImmunoTech Inc. (AMEX: AIM) Q1 2024 earnings conference call, held 2024-05-16. Replay captured from the company's public earnings webcast.

Chief Executive Officer
Scientific Officer
Not Provided
Analyst, Alliance Global Partners
Analyst, Ascendant Capital Markets
Watch the replay and follow the connected company analysis, news, and investor updates for Aim Immunotech Inc..
WEBVTT 00:00:00.009 -- 00:00:03.751 Hello and welcome to the AIM Immunotech first quarter 2024 00:00:03.751 -- 00:00:08.594 update conference call and webcast. As a brief reminder, all participants are currently 00:00:08.594 -- 00:00:13.056 in a listen-only mode. If anyone requires operator assistance during this event, please 00:00:13.056 -- 00:00:16.498 press star zero on your telephone keypad. 00:00:16.498 -- 00:00:20.361 Following the presentation, there will be a question and answer session. 00:00:20.361 -- 00:00:24.623 Note that this webcast is being recorded at the company's request and a replay will be 00:00:24.623 -- 00:00:29.699 made available on the company's website following the end of the event. 00:00:29.699 -- 00:00:33.682 At this time, I'd like to remind our listeners that remarks made during this webcast 00:00:33.682 -- 00:00:39.586 may state management's intentions, beliefs, expectations, or future projections. 00:00:39.586 -- 00:00:43.469 These are forward-looking statements and involve risks and uncertainties. 00:00:43.469 -- 00:00:47.532 Forward-looking statements on this call are made pursuant to the safe harbor provisions 00:00:47.532 -- 00:00:52.916 of the federal securities laws and are based on AIM Immunotech's current expectations, 00:00:52.916 -- 00:00:56.317 and actual results could differ materially. 00:00:57.242 -- 00:01:02.066 As a result, you should not place undue reliance on any forward-looking statements. 00:01:02.066 -- 00:01:06.869 Some of the factors that could cause actual results to differ materially from those contemplated 00:01:06.869 -- 00:01:11.493 by such forward-looking statements are discussed in the periodic reports AIM Immunotech 00:01:11.493 -- 00:01:14.735 files with the Securities and Exchange Commission. 00:01:14....